| Holding | Country | Type | Rating |
|---|
| US Government | United States | Fixed Income | — | 12.1% |
| Philip Morris | United States | Equity | — | 3.6% |
| Broadcom | United States | Equity | — | 3.4% |
| Astrazeneca | United Kingdom | Equity | — | 3.1% |
| Nestle | Switzerland | Equity | — | 2.2% |
| Holding | Country | Type | Rating |
|---|
| Microsoft | United States | Equity | — | 2.2% |
| TSMC | Taiwan | Equity | — | 2.2% |
| Umbs | United States | Fixed Income | — | 2.1% |
| Germany Government | Germany | Fixed Income | — | 1.7% |
| Gilead Sciences | United States | Equity | — | 1.6% |
| Sector |
|---|
| Equity | 65.9% | 100.0 |
| Energy | 4.1% | 6.2% |
| Materials | 1.9% | 2.9% |
| Industrials | 8.4% | 12.7% |
| Consumer discretionary | 5.2% | 7.9% |
| Consumer staples | 10.9% | 16.5% |
| Health care | 12.1% | 18.3% |
| Financials | 7.7% | 11.7% |
| Information technology | 12.5% | 19.0% |
| Communication services | 1.1% | 1.6% |
| Utilities | 0.9% | 1.4% |
| Real Estate | 1.2% | 1.8% |
| Fixed Income | 29.3% | 100.0 |
| Government | 21.7% | 74.1% |
| Corporate | 7.6% | 25.9% |
| Cash and equivalents | 4.9% | 100.0 |
| Name |
|---|
| North America | 60.5% |
| Europe | 21.3% |
| Emerging Markets | 7.7% |
| Japan | 3.9% |
| Asia Pacific ex Japan | 1.3% |
| Other | 0.5% |
| Cash & equivalents | 4.9% |